Symbols / BME Stock $40.94 +0.12% BlackRock Health Sciences Trust

Financial Services • Asset Management • United States • NYQ

BME (Stock) Chart

O: — H: — L: — C: — V: —

SMA 20: — SMA 50: — SMA 200: —

Stock Fundamentals

Scroll to Statements

Index	EQUITY
Sector	Financial Services
Industry	Asset Management
CEO	—
Exch · Country	NYQ · United States
Market Cap	529.11M
Enterprise Value	530.01M
Income	76.97M
Sales	7.74M
FCF (ttm)	-1.96M
Book/sh	43.97
Cash/sh	548.00
Employees	—
Insider 10d	—
IPO	Mar 29, 2005

Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout	53.13%

P/E	6.92
Forward P/E	—
PEG	—
P/S	68.40
P/B	0.93
P/C	—
EV/EBITDA	—
EV/Sales	68.51
Quick Ratio	0.23
Current Ratio	0.23
Debt/Eq	0.16
LT Debt/Eq	—

EPS (ttm)	5.92
EPS next Y	—
EPS Growth	—
Revenue Growth	7.60%
EPS Gr Q/Q	—
Rev Gr Q/Q	—
Earnings (next)	—
Earnings (prior)	—
ROA	0.19%
ROE	13.81%
ROIC	—
Gross Margin	100.00%
Oper. Margin	20.25%
Profit Margin	9.95%

Shs Outstand	12.92M
Shs Float	—
Insider Own	0.00%
Instit Own	20.56%
Short Float	0.39%
Short Ratio	0.93
Short Interest	50.53K
52W High	42.74
vs 52W High	-4.21%
52W Low	35.03
vs 52W Low	16.87%
Beta	0.59
Impl. Vol.	—
Rel Volume	0.90
Avg Volume	50.12K
Volume	45.33K

Target (mean)	—
Tgt Median	—
Tgt Low	—
Tgt High	—
# Analysts	—
Recom	None
Prev Close	$40.89
Price	$40.94
Change	0.12%

About

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.

Forward $/yr	—	TTM $/yr	—	Yield %	—
5Y avg yield %	—	Avg FY yield (hist.)	—	CAGR 3Y / 5Y	—

Dividends per share by fiscal year (bars). Yields use FY total dividends divided by year-end weekly close (approximate). Orange dashed line: benchmark average yield (5Y Yahoo average when available, else trailing average of FY yields). Calendar YTD year uses a darker teal bar and a gold YTD marker on the yield line (YTD dividends are incomplete vs a full FY).

Dividend payout history

Yield % uses close on or before ex-date and assumes ~4 payments per year (approximate).

Ex-date	Amount	Yield %	Special

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus

—

Mean price target

2. Current target

$40.94

Latest analyst target

3. DCF / Fair value

$-2.73

Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …

Ratings

Current target

$40.94

Low

—

High

—

Mean

—

News

RSS: Latest BME news

Banco Santander (BME:SAN) Stock Valuation Check After Recent Share Price Strength - simplywall.st Sat, 13 Jun 2026 04
How The Grifols (BME:GRF) Investment Story Is Shifting With New Analyst Caution - Yahoo Finance Sat, 23 May 2026 07
Grifols (BME:GRF) Stock Valuation Check After Prolonged Share Price Weakness - simplywall.st Fri, 12 Jun 2026 10
Assessing Iberdrola (BME:IBE) Valuation As Shares Trade Near Analyst Fair Value Estimates - Yahoo Finance Fri, 05 Jun 2026 12
How The Industria De Diseño Textil (BME:ITX) Story Is Shifting With Refined Analyst Targets - Yahoo Finance hu, 04 Jun 2026 07
Some Investors May Be Willing To Look Past B&M European Value Retail's (LON:BME) Soft Earnings - simplywall.st Wed, 10 Jun 2026 06
B&M (LSE:BME): Is the Discount Retailer Undervalued After a 33% Share Price Slide? - Yahoo Finance ue, 21 Oct 2025 07
Repsol (BME:REP) Valuation Check After Recent Share Price Strength And Renewable Energy Expansion - Yahoo Finance Wed, 06 May 2026 07
B&M European Value Retail (LON:BME) shareholders have endured a 20% loss from investing in the stock five years ago - Yahoo Finance Mon, 08 Sep 2025 07
Is Repsol (BME:REP) Still Attractive After A 115% One Year Share Price Surge? - Yahoo Finance Wed, 22 Apr 2026 07
How The BBVA (BME:BBVA) Investment Story Is Shifting With New Analyst Targets And Buybacks - Yahoo Finance Fri, 20 Mar 2026 07
Reassessing Amadeus IT Group (BME:AMS) Valuation After Recent Share Price Weakness - Yahoo Finance Sun, 08 Feb 2026 08
Is Telefónica (BME:TEF) Still Attractive After Its Recent Share Price Recovery? - Yahoo Finance ue, 03 Mar 2026 08
Assessing Acciona (BME:ANA) Valuation After A Powerful Year Of Total Shareholder Returns - Yahoo Finance hu, 07 May 2026 07
Assessing Inditex’s (BME:ITX) Valuation After Recent Share Price Momentum - Yahoo Finance hu, 26 Feb 2026 08

Insider Transactions

Filed Date	Insider	Relationship	Transaction	Shares	Price	Value
2026-01-30	XIE H ERIN	Other Executive	—	11,449	—	—
2026-01-30	LIU XIANG	Other Executive	—	389	—	—
2025-01-31	XIE H ERIN	Other Executive	—	13,471	—	—
2025-01-31	MCCLEMENTS KYLE	Other Executive	—	641	—	—
2025-01-31	ACCETTELLA CHRISTOPHER	Other Executive	—	202	—	—
2025-01-31	LIU XIANG	Other Executive	—	281	—	—

Financials

Statement View

Line Item	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Total Revenue	77.54 +222.10%	24.07 +17.94%	20.41 +178.59%	-25.97
Operating Revenue	77.54 +222.10%	24.07 +17.94%	20.41 +178.59%	-25.97
Operating Expense	0.57 -8.18%	0.62 +56.78%	0.39 -21.30%	0.50
Selling General And Administration	0.44 +23.49%	0.36 +18.89%	0.30 -17.43%	0.36
General And Administrative Expense	0.44 +23.49%	0.36 +18.89%	0.30 -17.43%	0.36
Other Operating Expenses	0.13 -51.23%	0.26 +176.58%	0.09 -31.45%	0.14
Total Unusual Items	0.00	—	—	—
Total Unusual Items Excluding Goodwill	0.00	—	—	—
Special Income Charges	0.00	—	—	—
Restructuring And Mergern Acquisition	0.00	—	—	—
Net Income	76.97 +228.16%	23.45 +17.17%	20.02 +175.62%	-26.47
Pretax Income	76.97 +228.16%	23.45 +17.17%	20.02 +175.62%	-26.47
Net Interest Income	-0.00 -11.54%	-0.00 -41.82%	-0.00	—
Interest Expense	0.00 +11.54%	0.00 +41.82%	0.00	—
Interest Income	0.00	0.00	0.00	—
Gain On Sale Of Security	28.42 -1.17%	28.76 +7.71%	26.70 +95.30%	13.67
Tax Rate For Calcs	0.00 +0.00%	0.00 +0.00%	0.00	0.00
Tax Effect Of Unusual Items	0.00	0.00	0.00	0.00
Net Income Including Noncontrolling Interests	76.97 +228.16%	23.45 +17.17%	20.02 +175.62%	-26.47
Net Income From Continuing Operation Net Minority Interest	76.97 +228.16%	23.45 +17.17%	20.02 +175.62%	-26.47
Net Income From Continuing And Discontinued Operation	76.97 +228.16%	23.45 +17.17%	20.02 +175.62%	-26.47
Net Income Continuous Operations	76.97 +228.16%	23.45 +17.17%	20.02 +175.62%	-26.47
Normalized Income	76.97 +228.16%	23.45 +17.17%	20.02 +175.62%	-26.47
Net Income Common Stockholders	76.97 +228.16%	23.45 +17.17%	20.02 +175.62%	-26.47
Diluted EPS	—	1.63 +13.19%	1.44 +168.57%	-2.10
Basic EPS	—	1.63 +13.19%	1.44 +168.57%	-2.10
Basic Average Shares	—	14.39 +3.52%	13.90 +10.28%	12.61
Diluted Average Shares	—	14.39 +3.52%	13.90 +10.28%	12.61
Diluted NI Availto Com Stockholders	76.97 +228.16%	23.45 +17.17%	20.02 +175.62%	-26.47

Line Item	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Total Assets	570.14 +3.59%	550.38 -7.67%	596.10 -1.65%	606.13
Cash And Cash Equivalents	0.00 -90.94%	0.01 +1032.58%	0.00 -82.87%	0.00
Cash Financial	0.00 -90.94%	0.01 +1032.58%	0.00 -82.87%	0.00
Receivables	0.43 +5.86%	0.40 -74.96%	1.62 -31.81%	2.37
Taxes Receivable	0.00	—	—	—
Prepaid Assets	—	0.00 -100.00%	0.01	—
Investments And Advances	569.69 +3.60%	549.88 -7.49%	594.40 -1.54%	603.68
Total Liabilities Net Minority Interest	1.83 -56.76%	4.24 -46.79%	7.97 +34.31%	5.93
Payables	0.92 -18.18%	1.12 +80.93%	0.62 -30.34%	0.89
Accounts Payable	0.21 -57.02%	0.49	—	0.23
Other Payable	0.71 +12.16%	0.63 +1.57%	0.62 -5.68%	0.66
Long Term Debt And Capital Lease Obligation	—	0.15 +150.57%	0.06 +1978.29%	0.00
Stockholders Equity	568.30 +4.06%	546.14 -7.14%	588.14 -2.01%	600.20
Common Stock Equity	568.30 +4.06%	546.14 -7.14%	588.14 -2.01%	600.20
Capital Stock	357.61 -6.17%	381.13 -8.74%	417.62 -1.57%	424.30
Common Stock	357.61 -6.17%	381.13 -8.74%	417.62 -1.57%	424.30
Share Issued	12.92 -2.50%	13.26 -4.94%	13.94 +0.60%	13.86
Ordinary Shares Number	12.92 -2.50%	13.26 -4.94%	13.94 +0.60%	13.86
Retained Earnings	210.69 +27.69%	165.00 -3.23%	170.52 -3.06%	175.90
Total Equity Gross Minority Interest	568.30 +4.06%	546.14 -7.14%	588.14 -2.01%	600.20
Total Capitalization	—	768.72 +30.69%	588.20 -2.00%	600.20
Invested Capital	—	768.72 +30.69%	588.20 -2.00%	600.20
Total Debt	—	0.15 +150.57%	0.06 +1978.29%	0.00
Net Debt	—	0.08 +34.20%	0.06 +1960.00%	0.00
Net Tangible Assets	568.30 +4.06%	546.14 -7.14%	588.14 -2.01%	600.20
Tangible Book Value	568.30 +4.06%	546.14 -7.14%	588.14 -2.01%	600.20
Available For Sale Securities	4.92 -81.49%	26.55 -15.43%	31.40 +31.53%	23.87
Cash Cash Equivalents And Federal Funds Sold	0.00 -90.94%	0.01 +1032.58%	0.00 -82.87%	0.00
Derivative Product Liabilities	0.00 -100.00%	2.82 -61.20%	7.27 +68.22%	4.32
Financial Assets Designatedas Fair Value Through Profitor Loss Total	564.78 +7.92%	523.33 -7.05%	563.00 -2.90%	579.81
Investmentin Financial Assets	569.69 +3.60%	549.88 -7.49%	594.40 -1.54%	603.68

Line Item	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Operating Cash Flow	54.58 -16.69%	65.52 +104.63%	32.02 +3763.28%	-0.87
Net Income From Continuing Operations	76.97 +228.16%	23.45 +17.17%	20.02 +175.62%	-26.47
Gain Loss On Investment Securities	-23.13 -155.65%	41.56 +225.50%	12.77 -49.48%	25.27
Change In Working Capital	0.74 +45.26%	0.51 +166.54%	-0.77 -335.45%	0.33
Change In Receivables	0.59 +173.66%	0.22 +1311.67%	-0.02 +87.87%	-0.15
Change In Prepaid Assets	0.00 -100.00%	0.01 +200.00%	-0.01	0.00
Change In Accrued Expense	0.00 +62.57%	0.00 +108.23%	-0.02 -753.45%	0.00
Change In Payable	0.08 +670.57%	0.01 +126.83%	-0.04 -291.45%	-0.01
Change In Other Current Assets	0.07 +3541.82%	-0.00 +54.84%	-0.00 -133.21%	0.01
Change In Other Current Liabilities	0.00 -100.00%	0.28 +141.14%	-0.68 -245.57%	0.46
Financing Cash Flow	-54.59 +16.68%	-65.52 -104.60%	-32.02 -3754.68%	0.88
Net Issuance Payments Of Debt	0.00 +100.00%	-0.06 -205.05%	0.06 +1878.29%	0.00
Issuance Of Debt	—	—	—	—
Long Term Debt Issuance	—	—	—	—
Net Long Term Debt Issuance	0.00 +100.00%	-0.06 -205.05%	0.06 +1878.29%	0.00
Net Common Stock Issuance	-13.98 +52.67%	-29.53 -1077.68%	3.02 -91.01%	33.62
Common Stock Payments	-13.98 +52.67%	-29.53	0.00	0.00
Common Stock Dividend Paid	-40.61 -13.05%	-35.92 -2.34%	-35.10 -7.25%	-32.73
Cash Dividends Paid	-40.61 -13.05%	-35.92 -2.34%	-35.10 -7.25%	-32.73
Repurchase Of Capital Stock	-13.98 +52.67%	-29.53	0.00	0.00
Net Other Financing Charges	0.00	0.00	0.00	0.00
Changes In Cash	-0.01 -199.80%	0.01 +316.00%	-0.00 -220.23%	0.00
Effect Of Exchange Rate Changes	0.00 +242.86%	-0.00 +75.00%	-0.00 -187.50%	0.00
Beginning Cash Position	0.01 +1032.58%	0.00 -82.87%	0.00 +224.79%	0.00
End Cash Position	0.00 -90.94%	0.01 +1032.58%	0.00 -82.87%	0.00
Free Cash Flow	54.58 -16.69%	65.52 +104.63%	32.02 +3763.28%	-0.87
Common Stock Issuance	—	—	3.02 -91.01%	33.62
Issuance Of Capital Stock	—	—	3.02 -91.01%	33.62

SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

42026-02-03 View
42026-02-03 View
42025-02-04 View
42025-02-04 View
42025-02-04 View
42025-02-04 View
8-K2025-01-21 View
42024-02-02 View
42024-02-02 View
42024-02-02 View
42024-02-02 View
42023-02-02 View
42023-02-02 View
42023-02-02 View
42023-02-02 View
42023-02-02 View
42022-02-03 View
42022-02-03 View
42022-02-02 View
42022-02-02 View

Trades

Date	User	Broker	Pattern	Type	Position Size	Entry Price	Trade P&L	Status

Posts

Published	Title	Author	Category

Headers
`Ctrl`+`Alt`+`1` or `Ctrl`+`Shift`+`1`	Heading 1
`Ctrl`+`Alt`+`2` or `Ctrl`+`Shift`+`2`	Heading 2
`Ctrl`+`Alt`+`3` or `Ctrl`+`Shift`+`3`	Heading 3
Shift+digit may show `!` `@` `#` on US keyboards; those chords work too.
Formatting
`Ctrl`+`B`	Bold
`Ctrl`+`I`	Italic
`Ctrl`+`U`	Underline
`Ctrl`+`Z`	Undo
`Ctrl`+`Shift`+`Z`	Redo
`Ctrl`+`K`	Add link
`Tab`	Indent list
`Shift`+`Tab`	Outdent list